8-106706430-G-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001198533.2(OXR1):c.909G>T(p.Met303Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000804 in 1,591,422 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001198533.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OXR1 | NM_001198533.2 | c.909G>T | p.Met303Ile | missense_variant | 9/17 | ENST00000517566.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OXR1 | ENST00000517566.7 | c.909G>T | p.Met303Ile | missense_variant | 9/17 | 1 | NM_001198533.2 | P3 |
Frequencies
GnomAD3 genomes ? AF: 0.000421 AC: 64AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000104 AC: 24AN: 230932Hom.: 0 AF XY: 0.0000639 AC XY: 8AN XY: 125158
GnomAD4 exome AF: 0.0000445 AC: 64AN: 1439174Hom.: 0 Cov.: 29 AF XY: 0.0000322 AC XY: 23AN XY: 715346
GnomAD4 genome ? AF: 0.000420 AC: 64AN: 152248Hom.: 0 Cov.: 32 AF XY: 0.000390 AC XY: 29AN XY: 74446
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 17, 2022 | The c.912G>T (p.M304I) alteration is located in exon 8 (coding exon 8) of the OXR1 gene. This alteration results from a G to T substitution at nucleotide position 912, causing the methionine (M) at amino acid position 304 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at